Life Sciences, Corporate Transactions & Regulatory Law
Covington & Burling LLP
Covington is a preeminent international law firm. What sets us apart is our ability to combine the tremendous strength in our corporate, disputes and investigations practices with deep knowledge of policy and policymakers, and one of the world’s leading regulatory practices. In an increasingly regulated world, we have an exceptional ability to help clients navigate their most complex business challenges.
We maintain a leading global life sciences practice, advising pharmaceutical, biotechnology, medical device, diagnostic, digital health, foods and other life sciences companies in the United Kingdom, Europe, the United States of America, Asia and other major markets on the full range of legal, regulatory and business issues that shape the industry. In recognition of the unique depth and breadth of our practice, Covington is the only firm to be ranked “Band I” for its life sciences practice in Chambers’ UK, Europe, USA, China and Global rankings.
Firm wide, over 250 lawyers actively practice in our life sciences industry group. We have expertise in every area of legal importance to the sector and deep experience with the business needs of life sciences companies and their investors in established and emerging markets.
Our capabilities in the UK include life sciences regulatory matters, inbound investments and acquisitions, capital markets transactions, commercial transactions, anti-corruption and compliance, dispute resolution, data protection and cybersecurity, international employment and mobility, business and human rights, project development and finance, insurance, trade controls, intellectual property, real estate, environment and tax.
In the life sciences sector, our regulatory team has extensive experience advising clients on UK, EU and other national laws governing clinical research, data protection, the regulatory status of borderline products, manufacturing controls, labeling and promotion, adverse event and other reporting obligations and product life cycle management. We also have extensive experience assisting clients in their interactions with NICE, NHS England and other regulatory, pricing and reimbursement authorities and with judicial review proceedings before the UK and EU courts.
Our corporate and commercial team have broad experience advising clients in the life sciences sector on UK-specific and cross-border investment transactions, mergers and acquisitions, strategic collaboration and licensing agreements, and co-development, co-promotion, manufacturing, supply and other commercial contracts. Covington’s approach combines our corporate expertise with our deep understanding of the life sciences industry and our commercial approach. Our corporate lawyers are supported by deal-experienced subject matter experts who understand the full range of regulatory, commercial, IP, compliance and other issues that arise in corporate transactions in the life sciences sector. This combination enables our clients to structure their transactions most advantageously and with a view towards meeting their legal and business requirements.
For further advice and assistance please contact:
020 7993 4255